IRIS-Synergy Cohort in the IRIS-DES Registry

Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )

NCT01350791 ·Status: COMPLETED

Orsiro™ Drug Eluting Stent in Routine Clinical Practice

NCT02039739 ·Status: COMPLETED

Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent

NCT00960908 ·Status: UNKNOWN

Consistent CTO Trial

NCT02227771 ·Status: UNKNOWN

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction

NCT02890589 ·Status: COMPLETED ·Phase: NA

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

NCT03507205 ·Status: COMPLETED

CONNECT DES Registrty

NCT04715594 ·Status: UNKNOWN

CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4

NCT05066789 ·Status: TERMINATED ·Phase: PHASE4

Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent

NCT01826552 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

NCT01186133 ·Status: RECRUITING

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )

NCT01365572 ·Status: UNKNOWN ·Phase: PHASE4

Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice

NCT03967158 ·Status: ACTIVE_NOT_RECRUITING

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

NCT05981911 ·Status: RECRUITING

Genoss DES Prospective Multicenter Registry

NCT03045913 ·Status: COMPLETED

A New Strategy Regarding Discontinuation of Dual Antiplatelet

NCT01145079 ·Status: COMPLETED ·Phase: PHASE4

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

NCT02193971 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)

NCT01350778 ·Status: COMPLETED

Coroflex® ISAR NEO PMCF Study

NCT05698732 ·Status: RECRUITING

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)

NCT01078038 ·Status: COMPLETED ·Phase: PHASE4

Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease

NCT00598637 ·Status: COMPLETED ·Phase: PHASE4

Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation

NCT02978456 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.

NCT02099617 ·Status: COMPLETED ·Phase: NA

Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)

NCT01350869 ·Status: COMPLETED

Evaluation of Effectiveness and Safety of NOBORI Stent

NCT01348360 ·Status: COMPLETED

Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI

NCT02015832 ·Status: COMPLETED